A real‐world study of user characteristics, safety and efficacy of open‐source closed‐loop systems and Medtronic 670G
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
We report a real‐world evaluation of the first commercially approved automated insulin delivery (AID) system, MiniMed 670G (670G), and open source‐automated insulin delivery (OS‐AID) systems. This was undertaken as a retrospective observational study in adults with type 1 diabetes using AID systems for 6 months or longer in a publicly funded health service using clinically validated data. Sixty‐eight adults (38 670G, 30 OS‐AID systems) were included. OS‐AID system users were younger, had a shorter diabetes duration and a higher education status. OS‐AID systems displayed a significantly better change in HbA1c (median −0.9% [−0.4%, −1.1%] vs. −0.1% [IQR −0.7%, 0.2%], P = .004) and time in range 3.9‐10 mmol/L (mean 78.5%, SD ± 12.0% vs. 68.2% ± 14.7%, P = .024) compared with 670G. Both systems showed minimal hypoglycaemia, with OS‐AID systems revealing significantly improved secondary outcomes of mean glucose and percentage of time more than 10 mmol/L, with a higher percentage of time of less than 3 mmol/L. OS‐AID system users displayed improved glycaemic outcomes with no clinical safety concerns compared with 670G, although higher weight‐adjusted insulin dose and weight gain were noted. The study highlights key differences in OS‐AID system user characteristics that are important for interpreting real‐world findings from recent OS‐AID system studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
One year clinical experience of the first commercial hybrid closed-loop system
Lal, R. A., Basina, M., Maahs, D. M., Hood, K., Buckingham, B., & Wilson, D. M. (2019) · Diabetes Care · doi:10.2337/dc19-0855 · Cited by 215
Lum, J. W., Bailey, R. J., Barnes-Lomen, V., Naranjo, D., Hood, K. K., Lal, R. A., Arbiter, B., Brown, A. S., DeSalvo, D. J., Pettus, J., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0535 · Cited by 150 · cited 4×
“The glycaemic outcomes reported are in line with previous observational studies for OS-AID systems and real-world data for 670G.(5-8,11) The reasons for the observed differences between systems are probably multifactorial.”
BackgroundMethodResultInfluential
Cited by
Open-source automated insulin delivery in type 1 diabetes
Burnside, M. J., Lewis, D. M., Crocket, H. R., Meier, R. A., Williman, J. A., Sanders, O. J., Jefferies, C. A., Faherty, A. M., Paul, R. G., Lever, C. S., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2203913 · Cited by 183
Braune, K., Lal, R. A., Petruželková, L., Scheiner, G., Winterdijk, P., Schmidt, S., Raimond, L., Hood, K. K., Riddell, M. C., Skinner, T. C., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00267-9 · Cited by 130
Self-citationReal-world evidence of automated insulin delivery system use
Considine, E. G., & Sherr, J. L. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0442 · Cited by 59
“42,44,46,48,49,55,57 Four reports included data that spanned from childhood to adulthood.”
Metadata
- Authors
- Jeyaventhan, R., Gallen, G., Choudhary, P., & Hussain, S.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2021-06-09
- Volume
- 23
- Issue
- 8
- Pages
- 1989-1994
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W3162077601
- Cited by
- 36
- References
- 3
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A real‐world study of user characteristics, safety and efficacy of open‐source closed‐loop systems and Medtronic 670G. https://app.cochat.ai/papers/10.1111/dom.14439
- The paper
- Jeyaventhan, R., Gallen, G., Choudhary, P., & Hussain, S. (2021). A real‐world study of user characteristics, safety and efficacy of open‐source closed‐loop systems and Medtronic 670G. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.14439
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.